Chile vs Switzerland: Immunization, Hib3
Chile
95.0%
in 2024
Switzerland
95.0%
in 2024
Chile rank
56th
Switzerland rank
56th
Immunization, Hib3 over time
- Chile
- Switzerland
How they compare
Chile currently reports 95.0% against 95.0% in Switzerland, a difference of 0.0%.
The two have swapped places 11 times across 27 shared years of data; in 1998 it was Chile ahead.
Chile ranks 56th and Switzerland ranks 56th of 191 countries.
Across the 4 decades both report, Chile averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Chile | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 92.5% | 84.0% | 8.5% | Chile |
| 2000s | 94.4% | 92.4% | 2.0% | Chile |
| 2010s | 93.6% | 95.0% | 1.4% | Switzerland |
| 2020s | 95.0% | 95.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Chile or Switzerland?
- Chile, at 95.0% against 95.0% in Switzerland as of 2024.
- What is the difference in immunization, hib3 between Chile and Switzerland?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Switzerland?
- 27 years are reported by both, from 1998 to 2024.
- How do Chile and Switzerland rank globally for immunization, hib3?
- Chile ranks 56th and Switzerland ranks 56th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.